Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v4-FR | Version v2-FR | |
---|---|---|
Language | French | French |
Date Updated | 2023-06-16 | 2023-05-23 |
Drug Identification Number | 02309238 | 02309238 |
Brand name | BREVIBLOC PREMIXED INJECTION | BREVIBLOC PREMIXED INJECTION |
Common or Proper name | BREVIBLOC PREMIXED INJECTION | BREVIBLOC PREMIXED INJECTION |
Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
Ingredients | ESMOLOL HYDROCHLORIDE | ESMOLOL HYDROCHLORIDE |
Strength(s) | 10MG | 10MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
Packaging size | 250mL | 250mL |
ATC code | C07AB | C07AB |
ATC description | BETA BLOCKING AGENTS | BETA BLOCKING AGENTS |
Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
Anticipated start date | 2023-05-19 | 2023-05-19 |
Actual start date | 2023-05-19 | 2023-05-19 |
Estimated end date | 2023-06-28 | 2023-06-16 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | DIN 02188880, Product code CA2L9119 Brevibloc (esmolol) vial, 100mg/10ml (10mg/mL) is available. | DIN 02188880, Product code CA2L9119 Brevibloc (esmolol) vial, 100mg/10ml (10mg/mL) is available. |
Health Canada comments |